129 related articles for article (PubMed ID: 18023421)
1. Differences in the substrate binding sites of murine and human proteinase 3 and neutrophil elastase.
Hajjar E; Korkmaz B; Reuter N
FEBS Lett; 2007 Dec; 581(29):5685-90. PubMed ID: 18023421
[TBL] [Abstract][Full Text] [Related]
2. Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments.
Wiesner O; Litwiller RD; Hummel AM; Viss MA; McDonald CJ; Jenne DE; Fass DN; Specks U
FEBS Lett; 2005 Oct; 579(24):5305-12. PubMed ID: 16182289
[TBL] [Abstract][Full Text] [Related]
3. Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.
Hajjar E; Broemstrup T; Kantari C; Witko-Sarsat V; Reuter N
FEBS J; 2010 May; 277(10):2238-54. PubMed ID: 20423453
[TBL] [Abstract][Full Text] [Related]
4. Computational prediction of the binding site of proteinase 3 to the plasma membrane.
Hajjar E; Mihajlovic M; Witko-Sarsat V; Lazaridis T; Reuter N
Proteins; 2008 Jun; 71(4):1655-69. PubMed ID: 18076025
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions.
Korkmaz B; Moreau T; Gauthier F
Biochimie; 2008 Feb; 90(2):227-42. PubMed ID: 18021746
[TBL] [Abstract][Full Text] [Related]
6. Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
Hajjar E; Korkmaz B; Gauthier F; Brandsdal BO; Witko-Sarsat V; Reuter N
J Med Chem; 2006 Feb; 49(4):1248-60. PubMed ID: 16480262
[TBL] [Abstract][Full Text] [Related]
7. Design and use of highly specific substrates of neutrophil elastase and proteinase 3.
Korkmaz B; Attucci S; Moreau T; Godat E; Juliano L; Gauthier F
Am J Respir Cell Mol Biol; 2004 Jun; 30(6):801-7. PubMed ID: 14693667
[TBL] [Abstract][Full Text] [Related]
8. A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate.
Epinette C; Croix C; Jaquillard L; Marchand-Adam S; Kellenberger C; Lalmanach G; Cadene M; Viaud-Massuard MC; Gauthier F; Korkmaz B
Biochem Pharmacol; 2012 Mar; 83(6):788-96. PubMed ID: 22209715
[TBL] [Abstract][Full Text] [Related]
9. Design of selective substrates of proteinase 3 using combinatorial chemistry methods.
Wysocka M; Lesner A; Guzow K; Mackiewicz L; Legowska A; Wiczk W; Rolka K
Anal Biochem; 2008 Jul; 378(2):208-15. PubMed ID: 18445466
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil elastase and proteinase 3 trafficking routes in myelomonocytic cells.
Källquist L; Rosén H; Nordenfelt P; Calafat J; Janssen H; Persson AM; Hansson M; Olsson I
Exp Cell Res; 2010 Nov; 316(19):3182-96. PubMed ID: 20828556
[TBL] [Abstract][Full Text] [Related]
11. Single residue determines the specificity of neutrophil elastase for Shigella virulence factors.
Averhoff P; Kolbe M; Zychlinsky A; Weinrauch Y
J Mol Biol; 2008 Apr; 377(4):1053-66. PubMed ID: 18295791
[TBL] [Abstract][Full Text] [Related]
12. Extended Cleavage Specificity of Human Neutrophil Elastase, Human Proteinase 3, and Their Distant Ortholog Clawed Frog PR3-Three Elastases With Similar Primary but Different Extended Specificities and Stability.
Fu Z; Thorpe M; Akula S; Chahal G; Hellman LT
Front Immunol; 2018; 9():2387. PubMed ID: 30459762
[TBL] [Abstract][Full Text] [Related]
13. Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases.
Korkmaz B; Jenne DE; Gauthier F
Int Immunopharmacol; 2013 Dec; 17(4):1198-205. PubMed ID: 23886601
[TBL] [Abstract][Full Text] [Related]
14. A new proteinase 3 substrate with improved selectivity over human neutrophil elastase.
Popow-Stellmaszyk J; Wysocka M; Lesner A; Korkmaz B; Rolka K
Anal Biochem; 2013 Nov; 442(1):75-82. PubMed ID: 23911525
[TBL] [Abstract][Full Text] [Related]
15. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates.
Korkmaz B; Attucci S; Hazouard E; Ferrandiere M; Jourdan ML; Brillard-Bourdet M; Juliano L; Gauthier F
J Biol Chem; 2002 Oct; 277(42):39074-81. PubMed ID: 12114510
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
17. Elafin and its precursor trappin-2 still inhibit neutrophil serine proteinases when they are covalently bound to extracellular matrix proteins by tissue transglutaminase.
Guyot N; Zani ML; Maurel MC; Dallet-Choisy S; Moreau T
Biochemistry; 2005 Nov; 44(47):15610-8. PubMed ID: 16300411
[TBL] [Abstract][Full Text] [Related]
18. Measurement of neutrophil elastase, proteinase 3, and cathepsin G activities using intramolecularly quenched fluorogenic substrates.
Korkmaz B; Attucci S; Epinette C; Pitois E; Jourdan ML; Juliano L; Gauthier F
Methods Mol Biol; 2012; 844():125-38. PubMed ID: 22262439
[TBL] [Abstract][Full Text] [Related]
19. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3.
Nobar SM; Zani ML; Boudier C; Moreau T; Bieth JG
FEBS J; 2005 Nov; 272(22):5883-93. PubMed ID: 16279952
[TBL] [Abstract][Full Text] [Related]
20. Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis.
Korkmaz B; Hajjar E; Kalupov T; Reuter N; Brillard-Bourdet M; Moreau T; Juliano L; Gauthier F
J Biol Chem; 2007 Jan; 282(3):1989-97. PubMed ID: 17088257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]